Search - tctmd.com

Displaying 301 - 320 of 1320

Sort: Relevancy | Date

Presentation TCT 2018

COAPT: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Gregg W. Stone

September 23, 2018

News Conference News TCT 2018

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Yael L. Maxwell

September 23, 2018

Presentation TCT 2018

Are Randomized Trials Feasible for Percutaneous Mechanical Support Devices?

Presenter: Nicole Ibrahim, David E. Kandzari, Holger Thiele

September 23, 2018

Presentation TCT 2018

REDUCE-FMR: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Horst Sievert

September 23, 2018

Presentation TCT 2018

Single Leaflet Detachment and Clip Embolization: Causes and Management

Presenter: Ted Feldman, Joachim Schofer, Samir R. Kapadia

September 23, 2018

Presentation TCT 2018

Stent Trials in High Bleeding Risk Patients: What is the Level of Evidence We Need?

Presenter: Peter Juni, Robert W. Yeh, Roxana Mehran

September 23, 2018

Presentation TCT 2018

SOLVE-TAVI: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Holger Thiele

September 23, 2018

Presentation TCT 2018

Non-Inferiority Trials Gone Wrong: Examples From the Recent Literature

Presenter: Peter Juni, Robert W. Yeh, David J. Cohen

September 23, 2018

Presentation TCT 2018

Transcatheter Tricuspid Valve Therapies: Challenging Technologies and Clinical Trial Pathways

Presenter: Jaime Raben, Josep Rodés-Cabau

September 23, 2018

Presentation TCT 2018

SORT OUT IX: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Lisette Okkels Jensen

September 23, 2018

Presentation TCT 2018

Most Frequent Errors I See in the Analysis and Interpretation of Trials

Presenter: Peter Juni, Robert W. Yeh

September 23, 2018

Presentation TCT 2018

How to Make Trials Larger, Simpler and Less Expensive

Presenter: Peter Juni, Robert W. Yeh, Matthew T. Roe

September 23, 2018

Presentation TCT 2018

Clinical Impact of Valve Thrombosis After TAVR

Presenter: Martina Kelly Speight

September 23, 2018

Presentation TCT 2018

LEADERS FREE II: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Mitchell W. Krucoff

September 23, 2018

Presentation TCT 2018

Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement?

Presenter: Deepak L. Bhatt, Tullio Palmerini, Usman Baber

September 23, 2018

Presentation TCT 2018

Sham Controlled Trials for Devices Are Unethical, Unfeasible, and Unnecessary!

Presenter: Ajay J. Kirtane, Stuart J. Pocock, William F. Fearon

September 23, 2018

Presentation TCT 2018

Sham Controlled Trials Should Be the New Gold Standard for Device Trials!

Presenter: Ajay J. Kirtane, Stuart J. Pocock, Bernard J. Gersh

September 23, 2018

Presentation TCT 2018

ORBITA in the Spotlight: How I Would Have Done the Trial Differently

Presenter: Ajay J. Kirtane, Stuart J. Pocock

September 23, 2018

Presentation TCT 2018

ORBITA in the Spotlight: How I Interpret ORBITA as an Interventional Cardiologist

Presenter: Ajay J. Kirtane, Stuart J. Pocock, Rasha Al-Lamee

September 23, 2018

Presentation TCT 2018

How Strong are the Pharmacodynamic Data and Clinical Evidence for Crushed Ticagrelor and Prasugrel?

Presenter: John A. Bittl, C. Michael Gibson, Dimitrios Alexopoulos

September 23, 2018

Advertisement

COAPT: Summary and Clinical Implications

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Are Randomized Trials Feasible for Percutaneous Mechanical Support Devices?

REDUCE-FMR: Summary and Clinical Implications

Single Leaflet Detachment and Clip Embolization: Causes and Management

Stent Trials in High Bleeding Risk Patients: What is the Level of Evidence We Need?

SOLVE-TAVI: Summary and Clinical Implications

Non-Inferiority Trials Gone Wrong: Examples From the Recent Literature

Transcatheter Tricuspid Valve Therapies: Challenging Technologies and Clinical Trial Pathways

SORT OUT IX: Summary and Clinical Implications

Most Frequent Errors I See in the Analysis and Interpretation of Trials

How to Make Trials Larger, Simpler and Less Expensive

Clinical Impact of Valve Thrombosis After TAVR

LEADERS FREE II: Summary and Clinical Implications

Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement?

Sham Controlled Trials for Devices Are Unethical, Unfeasible, and Unnecessary!

Sham Controlled Trials Should Be the New Gold Standard for Device Trials!

ORBITA in the Spotlight: How I Would Have Done the Trial Differently

ORBITA in the Spotlight: How I Interpret ORBITA as an Interventional Cardiologist

How Strong are the Pharmacodynamic Data and Clinical Evidence for Crushed Ticagrelor and Prasugrel?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content